Dynabeads® FlowComp™ Human CD3 contain magnetic beads that provide a robust and versatile tool to positively isolate pure CD3+ T-cells from whole blood, bone marrow, buffy coat, mononuclear cells (MNC), or tissue digests. The cells can be released from the beads using the FlowComp™ Release Buffer.
• Rapid isolation of CD3+ T-cells from any sample – no columns required
• Pure and bead-free CD3+ T-cells for any downstream application
Excellent Yield, Purity, and Viability of Recovered Cells
Dynabeads® FlowComp™ Human CD3 contains uniform, superparamagnetic beads (2.8 µm diameter) that enable easy isolation of human CD3+ cells directly from any sample via a three-step process. First, the FlowComp™ Human CD3 Antibody is mixed with the sample in a tube where it binds to the target cells during a short incubation. Then, the CD3+ T-cells that have bound the specific antibodies are captured by the FlowComp™ Dynabeads® and separated from unbound cells using a magnet. Finally, the target cells are released from the beads by adding the FlowComp™ Release buffer. This fast and gentle isolation method does not require the use of columns, and helps ensure high purity, recovery and viability of the isolated CD3+ cells. The cells can be used in any downstream application.
For Research Use Only. Not intended for animal or human diagnostic or therapeutic use.
原厂资料：
Dynabeads® FlowComp™ Human CD3 contain magnetic beads that provide a robust and versatile tool to positively isolate pure CD3+ T-cells from whole blood, bone marrow, buffy coat, mononuclear cells (MNC), or tissue digests. The cells can be released from the beads using the FlowComp™ Release Buffer. • Rapid isolation of CD3+ T-cells from any sample – no columns required • Pure and bead-free CD3+ T-cells for any downstream application
Excellent Yield, Purity, and Viability of Recovered Cells Dynabeads® FlowComp™ Human CD3 contains uniform, superparamagnetic beads (2.8 µm diameter) that enable easy isolation of human CD3+ cells directly from any sample via a three-step process. First, the FlowComp™ Human CD3 Antibody is mixed with the sample in a tube where it binds to the target cells during a short incubation. Then, the CD3+ T-cells that have bound the specific antibodies are captured by the FlowComp™ Dynabeads® and separated from unbound cells using a magnet. Finally, the target cells are released from the beads by adding the FlowComp™ Release buffer. This fast and gentle isolation method does not require the use of columns, and helps ensure high purity, recovery and viability of the isolated CD3+cells. The cells can be used in any downstream application.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
